Phase I/II Study of KP-100IT in Acute Spinal Cord Injury

NCT02193334 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Spinal Cord Injuries

Interventions

DRUG: KP-100IT
DRUG: Placebo

Sponsor

Kringle Pharma, Inc.